What is the ROCE (Return on Capital Employed) of Cytogen this year?
The ROCE of Cytogen is -0.22 undefined this year.
Cytogen ROCE 2024
Cytogen ROCE
-0.22
Ticker
217330.KQ
ISIN
KR7217330000
In 2024, Cytogen's return on capital employed (ROCE) was -0.22, a -89.13% increase from the -2.03 ROCE in the previous year.
Cytogen Aktienanalyse
What does Cytogen do?
Cytogen ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Cytogen's Return on Capital Employed (ROCE)
Cytogen's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Cytogen's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Cytogen's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Cytogen’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Cytogen stock
How has the ROCE (Return on Capital Employed) of Cytogen developed compared to the previous year?
The ROCE of Cytogen has increased by -89.13% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Cytogen?
A high Return on Capital Employed (ROCE) indicates that Cytogen has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Cytogen?
A low ROCE (Return on Capital Employed) can indicate that Cytogen has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Cytogen impact the company?
An increase in the ROCE of Cytogen can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Cytogen affect the company?
A decrease in ROCE of Cytogen can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Cytogen?
Some factors that can affect Cytogen's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Cytogen so important for investors?
The ROCE of Cytogen is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Cytogen take to improve the ROCE?
To improve the ROCE, Cytogen can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Cytogen pay?
Over the past 12 months, Cytogen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cytogen is expected to pay a dividend of 0 KRW.
What is the dividend yield of Cytogen?
The current dividend yield of Cytogen is .
When does Cytogen pay dividends?
Cytogen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cytogen?
Cytogen paid dividends every year for the past 0 years.
What is the dividend of Cytogen?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cytogen located?
Cytogen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cytogen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cytogen from 11/10/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 11/10/2024.
When did Cytogen pay the last dividend?
The last dividend was paid out on 11/10/2024.
What was the dividend of Cytogen in the year 2023?
In the year 2023, Cytogen distributed 0 KRW as dividends.
In which currency does Cytogen pay out the dividend?
The dividends of Cytogen are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cytogen
Our stock analysis for Cytogen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cytogen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.